Stereotactic Body Radiotherapy (SBRT) and Sorafenib in Patients With Metastatic, Recurrent, or Unresectable Renal Cell Cancer (RCC)
Clinical trial NCT00672178 · TERMINATED
Trial details
- NCT number
- NCT00672178
- Sponsor
- Duke University
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2009-09-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.